- Home
- KRKR vs SYBX Comparison
KRKR vs SYBX Comparison
Compare KRKR & SYBX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- KRKR
- SYBX
- Stock Information
- Founded
- KRKR 2010
- SYBX N/A
- Country
- KRKR China
- SYBX United States
- Employees
- KRKR N/A
- SYBX N/A
- Industry
- KRKR Business Services
- SYBX Biotechnology: Pharmaceutical Preparations
- Sector
- KRKR Consumer Discretionary
- SYBX Health Care
- Exchange
- KRKR Nasdaq
- SYBX Nasdaq
- Market Cap
- KRKR 11.7M
- SYBX 13.6M
- IPO Year
- KRKR 2019
- SYBX N/A
- Fundamental
- Price
- KRKR $5.78
- SYBX $1.23
- Analyst Decision
- KRKR
- SYBX
- Analyst Count
- KRKR 0
- SYBX 0
- Target Price
- KRKR N/A
- SYBX N/A
- AVG Volume (30 Days)
- KRKR 2.7K
- SYBX 8.2K
- Earning Date
- KRKR 03-11-2025
- SYBX 08-07-2025
- Dividend Yield
- KRKR N/A
- SYBX N/A
- EPS Growth
- KRKR N/A
- SYBX N/A
- EPS
- KRKR N/A
- SYBX 0.21
- Revenue
- KRKR $31,657,328.00
- SYBX N/A
- Revenue This Year
- KRKR $182.55
- SYBX N/A
- Revenue Next Year
- KRKR N/A
- SYBX N/A
- P/E Ratio
- KRKR N/A
- SYBX $5.92
- Revenue Growth
- KRKR N/A
- SYBX N/A
- 52 Week Low
- KRKR $2.76
- SYBX $0.90
- 52 Week High
- KRKR $12.99
- SYBX $1.88
- Technical
- Relative Strength Index (RSI)
- KRKR 53.05
- SYBX 52.81
- Support Level
- KRKR $5.55
- SYBX $1.17
- Resistance Level
- KRKR $5.88
- SYBX $1.27
- Average True Range (ATR)
- KRKR 0.09
- SYBX 0.04
- MACD
- KRKR -0.04
- SYBX -0.01
- Stochastic Oscillator
- KRKR 38.98
- SYBX 40.00
About KRKR 36Kr Holdings Inc.
36KR Holdings Inc is a holding company and conducts its business mainly through its subsidiaries, a VIE, and subsidiaries of the VIE. The Group is engaging in providing content and business services to new economy participants in the PRC. Its content production process includes content creation, content editing, screening and monitoring, and content distribution. The Group mainly generates revenues from providing online advertising services, enterprise value-added services, and subscription services. The Group's principal operations and geographic markets are substantially located in PRC.
About SYBX Synlogic Inc.
Synlogic Inc is a biopharmaceutical company focuses on rare metabolic disorders, with a lead program in phenylketonuria (PKU) and homocystinuria (HCU). The company's pipeline includes therapeutics for enteric hyperoxaluria, gout, and cystinuria. Using a proprietary approach, the company engineer GI-restricted, oral medicines from well-characterized probiotics. These drug candidates target specific biological pathways, leveraging Escherichia coli Nissle 1917 for consistency and safety. Engineered to be non-colonizing and reversible, the company offer oral administration, simplifying shipping and storage. The company operates in one segment-discovery and development of Synthetic Biotics-pioneering transformative treatments for serious diseases.